Stephen H. Curry
Impact in
- Psychiatry and Mental health top 2%
- Schizophrenia research and treatment
- Epilepsy research and treatment
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
Papers in
- Pharmacology 21
- Antibiotics Pharmacokinetics and Efficacy 17
- Pharmacogenetics and Drug Metabolism 10
-
- Analytical Methods in Pharmaceuticals 15
- Co-authors
- W.C. McCallumPeter W. StacpooleThomas G. BaumgartnerG. P. MouldEloise HarmanRobin WhelptonRobert I. MisbinM. Lader
- Journals
- Journal of Pharmacy and Pharmacology (16 papers)Biopharmaceutics & Drug Disposition (10 papers)Clinical Pharmacology & Therapeutics (6 papers)Annals of the New York Academy of Sciences (5 papers)Electroencephalography and Clinical Neurophysiology (3 papers)
- Partner nations
- United StatesUnited KingdomMexico
In The Last Decade
Stephen H. Curry
127 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 153
- Psychiatry and Mental health 721
- Pharmacology 319
- Nephrology 247
- Cognitive Neuroscience 630
- Clinical Biochemistry 190
Countries citing papers authored by Stephen H. Curry
This map shows the geographic impact of Stephen H. Curry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen H. Curry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen H. Curry more than expected).
Fields of papers citing papers by Stephen H. Curry
This network shows the impact of papers produced by Stephen H. Curry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen H. Curry. The network helps show where Stephen H. Curry may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen H. Curry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2020 | 1 | |
| 3 | Absorption and Distribution of Moxifloxacin, Ofloxacin and Gatifloxacin into Ocular Tissues and Plasma Following Topical Ocular Administration to Pigmented Rabbits. | 2004 | 2 |
| 4 | 1996 | 141 | |
| 5 | 1995 | 8 | |
| 6 | 1995 | 5 | |
| 7 | 1995 | 1 | |
| 8 | 1994 | 43 | |
| 9 | 1992 | 10 | |
| 10 | 1992 | 22 | |
| 11 | 1987 | 9 | |
| 12 | 1987 | 3 | |
| 13 | 1984 | 13 | |
| 14 | 1982 | 36 | |
| 15 | 1980 | 66 | |
| 16 | Clorazepate: double blind crossover comparison of a single nightly dose with diazepam thrice daily in anxiety. | 1977 | 8 |
| 17 | Plasma concentrations in the monkey (Macaca mulatta) of six related benzodiazepines after intraperitoneal injection [proceedings]. | 1976 | 1 |
| 18 | Proceedings: Clinical pharmacology of chlorpromazine. | 1972 | 5 |
| 19 | 1971 | 7 | |
| 20 | 1970 | 1 |
About Stephen H. Curry
Stephen H. Curry is a scholar working on Pharmacology, Pharmacology, Analytical Chemistry, Psychiatry and Mental health and Nephrology, having authored 130 papers that have together received 3.3k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Analytical Methods in Pharmaceuticals (15 papers), Epilepsy research and treatment (13 papers), Neuroscience and Neuropharmacology Research (10 papers), Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (10 papers), Schizophrenia research and treatment (10 papers) and Pharmaceutical studies and practices (7 papers). The work is most often cited by research in Psychiatry and Mental health (721 citations), Pharmacology (319 citations), Nephrology (247 citations), Cognitive Neuroscience (630 citations) and Clinical Biochemistry (190 citations). Stephen H. Curry has collaborated with scholars based in United States, United Kingdom and Mexico. Frequent co-authors include W.C. McCallum, Peter W. Stacpoole, Thomas G. Baumgartner, G. P. Mould, Eloise Harman, Robin Whelpton, Robert I. Misbin, M. Lader, D. Papakōstopoulos and P.V. Pocock. Their work appears in journals such as Journal of Pharmacy and Pharmacology, Biopharmaceutics & Drug Disposition, Clinical Pharmacology & Therapeutics, Annals of the New York Academy of Sciences and Electroencephalography and Clinical Neurophysiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.